Reckitt Benckiser publishes base prospectus for £10bn EMTN programme

Published 01/09/2025, 08:52
Reckitt Benckiser publishes base prospectus for £10bn EMTN programme

LONDON - Reckitt Benckiser Group plc announced Monday that it has published the base prospectus for its £10,000,000,000 Euro Medium Term Note (EMTN) Programme. The programme is operated by Reckitt Benckiser Treasury Services plc and guaranteed by Reckitt Benckiser Group plc.

According to the company statement, the base prospectus has been submitted to the National Storage Mechanism and will be available for inspection through the Financial Conduct Authority’s website. The document can also be accessed via Reckitt’s corporate website.

The EMTN programme provides a framework for the company to issue medium-term debt securities. Such programmes are commonly used by large corporations to maintain flexibility in their debt financing strategies.

Reckitt Benckiser Group, which trades under the name Reckitt, is a global consumer health and hygiene company with brands including Dettol, Durex, Finish, and Lysol.

The base prospectus contains information about the terms and conditions of potential notes that may be issued under the programme. The securities referenced in the announcement have not been registered under the U.S. Securities Act of 1933 and are subject to U.S. tax law requirements.

This announcement is based on a press release statement issued by the company and does not constitute an offer to sell or solicitation to acquire securities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.